Urothelial Carcinoma Market Is Projected To Boom By 2036 Owing To The Increasing Adoption Of Immunotherapies And Antibody-Drug Conjugates Delveinsight. The ma ...
A new clinical mini-review proposes an evidence-informed framework for deciding which bladder cancer patients should be ...
Ubiquitination-regulated molecular events exert crucial regulatory effects on the initiation and progression of bladder cancer (BCa), yet clinically actionable ...
Urothelial carcinoma accounts for the vast majority of bladder cancers and presents along a continuum from non-muscle-invasive lesions to muscle-invasive and metastatic disease. Non-muscle-invasive ...
In a 108-patient tissue study, mismatch repair deficiency was absent from bladder urothelial carcinoma cases and stable ...
Nice to meet you. I run the "Anticancer Drug Encyclopedia." I am a practicing pharmacist and hold certifications and ...
Urothelium is the term for the mucous membrane that lines the urinary tract. This includes the renal pelvis, ureter, urinary bladder and the upper part of the urethra. In the vast majority of cases, ...
Neoadjuvant cisplatin-based chemotherapy before radical cystectomy (RC) has been standard-of-care treatment for muscle-invasive bladder cancer (MIBC) for over two decades. The study aimed to explore ...
Phase 1 clinical trial to evaluate local intravesical administration of UGN-501UGN-501 is a differentiated investigational next-generation ...
Stage 1 bladder cancer involves lamina propria invasion without detrusor involvement, requiring both eradication of index lesions and mitigation of field-change–driven multifocal recurrence risk.
JCO Precision Oncology Conversations podcasts feature discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations ...
The online calculator enhances accessibility, enabling broader application in diverse healthcare settings. Moreover, the genetic findings provide a rationale for closer monitoring of urinary system ...